Human interleukin 3: effects on normal and leukemic cells

The effects of recombinant human interleukin 3 (IL3) on normal bone marrow cells and human leukemic cells were studied. In clonal assays, IL3 supported the growth of all colony types including megakaryocytes. Erythroid colonies were formed in the presence of IL3 and erythropoietin, but not in the ab...

Full description

Saved in:
Bibliographic Details
Published in:Growth factors (Chur, Switzerland) Vol. 1; no. 2; p. 101
Main Authors: Barber, K E, Crosier, P S, Purdie, K J, Buchanan, J M, Cattermole, J A, Watson, J D, Gillis, S
Format: Journal Article
Language:English
Published: England 1989
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The effects of recombinant human interleukin 3 (IL3) on normal bone marrow cells and human leukemic cells were studied. In clonal assays, IL3 supported the growth of all colony types including megakaryocytes. Erythroid colonies were formed in the presence of IL3 and erythropoietin, but not in the absence of erythropoietin. Replating experiments using blast cell colonies derived from a cell population enriched for progenitor cells by fluorescence-activated cell sorting with the monoclonal antibody 3C5, showed that IL3 supported the continued replating of colonies. The clonal proliferation of human bone marrow cells in response to IL3 was inhibited by tumor necrosis factor and by lymphotoxin, but not by interferon-gamma. In suspension cultures, IL3 supported the proliferation of mast cells. Human IL3 had no effect on the growth responses, morphology, cytochemistry, or clonogenicity of the human leukemic cell lines HL60, U-937, KG1a, and HEL. Transcripts for IL3 mRNA were not detectable in these cells, nor in the K562 cell line, implying that autocrine secretion of IL3 was not the mechanism by which these leukemias were maintained. Although cells derived from the bone marrow or peripheral blood of twenty patients with myeloproliferative disorders, myelodysplastic syndromes or acute myeloid leukemia frequently showed proliferative responses to IL3, mRNA transcripts for IL3 were not detected in these cells.
AbstractList The effects of recombinant human interleukin 3 (IL3) on normal bone marrow cells and human leukemic cells were studied. In clonal assays, IL3 supported the growth of all colony types including megakaryocytes. Erythroid colonies were formed in the presence of IL3 and erythropoietin, but not in the absence of erythropoietin. Replating experiments using blast cell colonies derived from a cell population enriched for progenitor cells by fluorescence-activated cell sorting with the monoclonal antibody 3C5, showed that IL3 supported the continued replating of colonies. The clonal proliferation of human bone marrow cells in response to IL3 was inhibited by tumor necrosis factor and by lymphotoxin, but not by interferon-gamma. In suspension cultures, IL3 supported the proliferation of mast cells. Human IL3 had no effect on the growth responses, morphology, cytochemistry, or clonogenicity of the human leukemic cell lines HL60, U-937, KG1a, and HEL. Transcripts for IL3 mRNA were not detectable in these cells, nor in the K562 cell line, implying that autocrine secretion of IL3 was not the mechanism by which these leukemias were maintained. Although cells derived from the bone marrow or peripheral blood of twenty patients with myeloproliferative disorders, myelodysplastic syndromes or acute myeloid leukemia frequently showed proliferative responses to IL3, mRNA transcripts for IL3 were not detected in these cells.
Author Barber, K E
Purdie, K J
Watson, J D
Buchanan, J M
Crosier, P S
Gillis, S
Cattermole, J A
Author_xml – sequence: 1
  givenname: K E
  surname: Barber
  fullname: Barber, K E
  organization: Department of Immunobiology, School of Medicine, University of Auckland, New Zealand
– sequence: 2
  givenname: P S
  surname: Crosier
  fullname: Crosier, P S
– sequence: 3
  givenname: K J
  surname: Purdie
  fullname: Purdie, K J
– sequence: 4
  givenname: J M
  surname: Buchanan
  fullname: Buchanan, J M
– sequence: 5
  givenname: J A
  surname: Cattermole
  fullname: Cattermole, J A
– sequence: 6
  givenname: J D
  surname: Watson
  fullname: Watson, J D
– sequence: 7
  givenname: S
  surname: Gillis
  fullname: Gillis, S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/2624775$$D View this record in MEDLINE/PubMed
BookMark eNotj81KAzEUhbOo1Lb6AC6EvMDozd8kcSdFrVBwo-tyM7mB0ZlMmcwsfHtb7OrAd-DjnDVb5CETY3cCHpQA_wjOWyu88-BBeiFhwVZnVp2gvmbrUr4BhNJWLNlS1lJba1bM7-YeM2_zRGNH80-buXrilBI1U-FD5nkYe-w45sjPPfVtwxvqunLDrhJ2hW4vuWFfry-f2121_3h73z7vq0YrOVWSUgQ4LUtBJN3UOhgwQsWAaFKsTbTJJ_IugJHonKQAOqJxmAL5iLXcsPt_73EOPcXDcWx7HH8PlwvyD12vSKQ
CitedBy_id crossref_primary_10_1111_j_1365_3024_2009_01147_x
crossref_primary_10_1002__SICI_1096_8652_199704_54_4_301__AID_AJH7_3_0_CO_2_Z
crossref_primary_10_1016_0145_2126_93_90016_E
crossref_primary_10_3109_10428199209053585
crossref_primary_10_1111_j_1600_0609_1999_tb01845_x
crossref_primary_10_1007_BF01695808
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.3109/08977198909029120
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
ExternalDocumentID 2624775
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
0BK
0R~
29I
36B
4.4
53G
5GY
5VS
A8Z
AACCU
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACIEZ
ADCVX
ADXPE
AECIN
AENEX
AEOZL
AFAUU
AFKVX
AFQCT
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
CGR
COF
CS3
CUY
CVF
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EAP
EBC
EBD
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
EPL
ESTFP
ESX
F5P
H13
HZ~
JFOCU
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
NPM
NUSFT
O9-
P2P
QRXOQ
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFL
TFW
TUROJ
TUS
UDS
UHWXJ
V1S
~1N
ID FETCH-LOGICAL-c432t-2efd00771fb1f4c64b50513dbaa5fd65d7f9fe98b052a882eb04da58afbe9da62
ISSN 0897-7194
IngestDate Tue Oct 15 23:11:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c432t-2efd00771fb1f4c64b50513dbaa5fd65d7f9fe98b052a882eb04da58afbe9da62
PMID 2624775
ParticipantIDs pubmed_primary_2624775
PublicationCentury 1900
PublicationDate 1989-00-00
PublicationDateYYYYMMDD 1989-01-01
PublicationDate_xml – year: 1989
  text: 1989-00-00
PublicationDecade 1980
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Growth factors (Chur, Switzerland)
PublicationTitleAlternate Growth Factors
PublicationYear 1989
SSID ssj0013471
Score 1.3654693
Snippet The effects of recombinant human interleukin 3 (IL3) on normal bone marrow cells and human leukemic cells were studied. In clonal assays, IL3 supported the...
SourceID pubmed
SourceType Index Database
StartPage 101
SubjectTerms Blood Cells - drug effects
Blood Cells - physiology
Bone Marrow - drug effects
Bone Marrow Cells
Cell Division - physiology
Cell Line
Cells, Cultured
Humans
Interleukin-3 - genetics
Interleukin-3 - physiology
Leukemia - blood
Recombinant Proteins - pharmacology
RNA, Messenger - metabolism
RNA, Neoplasm - metabolism
Tumor Cells, Cultured
Title Human interleukin 3: effects on normal and leukemic cells
URI https://www.ncbi.nlm.nih.gov/pubmed/2624775
Volume 1
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LS-wwFA4ziuBGfOKbLMSNFKdp-nLnY1QERbhecCdJk-CgdkRbRH-9JzmZTpnLFV24KSXJpG2-M8l5H0J2lI6KhJlewAuAgRuZB1JpHsiehsNcR5kunOriT3p1m530eb_TeRtJ_U3bryINbYC1jZz9AdrNpNAA94A5XAF1uH4Ld9TK2ywQL4-6fhiUe5GrvjPy2yj3SsumYoYAO8J5x1v9_WubUT0D8by6b8rxWFvvfY01ut4G1QfGCLfUCNZu4f0zWsENcAQPsPV6rGO9roEoNQ5ttNRHtQ1BRm3shVfRKtF4WzXKCL9n5WmQhli3uNlgW3TEWptliL-c3MQjzIFqp0rtM6znaB66kLmqBeDzk0OQJYynWHzly86JrNq-p0u6wCJZLvr4cmx8Qjm9-RY0htvX2v_npWbJjJ9qQi5x_MnNPJnzggU9RIpYIB1dLpKlw1JUw6d3ukudq6-zoSyR3BEJbREJjQ6oJxE6LCmSCAWI6YhEqCORZfL3tH9zfB74GhpBwSNWBUwbZVM2hUaGhhcJl8DyhpGSQsRGJbFKTW50nslezARIW1r2uBJxJozUuRIJWyFT5bDUq4TGMCZTBU94xmBunUkBvCgsRGiKFI7MNbKCC3D3jIlS7vzKrP-vY4PMjolok0wb-A_qLdJ9VfW2g-QTb3VLTg
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+interleukin+3%3A+effects+on+normal+and+leukemic+cells&rft.jtitle=Growth+factors+%28Chur%2C+Switzerland%29&rft.au=Barber%2C+K+E&rft.au=Crosier%2C+P+S&rft.au=Purdie%2C+K+J&rft.au=Buchanan%2C+J+M&rft.date=1989-01-01&rft.issn=0897-7194&rft.volume=1&rft.issue=2&rft.spage=101&rft_id=info:doi/10.3109%2F08977198909029120&rft_id=info%3Apmid%2F2624775&rft_id=info%3Apmid%2F2624775&rft.externalDocID=2624775
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0897-7194&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0897-7194&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0897-7194&client=summon